Chinese medicine yin-yang; Peptide arrays fight terrorists;

> Tianyin Pharmaceutical, a maker of modernized traditional Chinese medicines, has received GMP certification for a new production facility from China's State Food and Drug Administration. Release

> Arrayit Corp. will provide its proprietary peptide microarray manufacturing platform to the U.S. Centers for Disease Control and Prevention for use in deciphering and combating infectious agents from terrorist attacks. Announcement

> Some 400 manufacturing jobs have been cut at a Teva plant in Prague, to be replaced next year by 300 jobs following a main plant expansion. Release

> Dionex, a maker of liquid chromatography analysis systems, is picking up HPLC assets from ESA Biosciences. Announcement

> Vetter of Ravensburg, Germany, is opening a 25,000-square-foot customer service facility in Chicago for the aseptic filling of very small quantities of injection products.  Release

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.